Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,021 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
Green TC, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D. Green TC, et al. Among authors: gray m. Subst Abus. 2022;43(1):901-905. doi: 10.1080/08897077.2021.2010162. Subst Abus. 2022. PMID: 35213293 Free PMC article.
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains.
Green TC, Silcox J, Bolivar D, Gray M, Floyd AS, Irwin AN, Hansen RN, Hartung DM, Bratberg J. Green TC, et al. Among authors: gray m. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):71-78. doi: 10.1016/j.japh.2023.10.014. Epub 2023 Oct 18. J Am Pharm Assoc (2003). 2024. PMID: 37863398
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
Irwin AN, Gray M, Ventricelli D, Boggis JS, Bratberg J, Floyd AS, Silcox J, Hartung DM, Green TC. Irwin AN, et al. Among authors: gray m. Res Social Adm Pharm. 2024 May;20(5):512-519. doi: 10.1016/j.sapharm.2024.02.001. Epub 2024 Feb 10. Res Social Adm Pharm. 2024. PMID: 38395644
Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
Seaman A, Leichtling G, Stack E, Gray M, Pope J, Larsen JE, Leahy JM, Gelberg L, Korthuis PT. Seaman A, et al. Among authors: gray m. AIDS Behav. 2021 May;25(5):1331-1339. doi: 10.1007/s10461-020-03141-4. Epub 2021 Jan 20. AIDS Behav. 2021. PMID: 33471243 Free PMC article.
Determination of Bovine Lactoferrin in Powdered Infant Formula and Adult Nutritionals by Heparin Affinity Extraction and Reverse-Phase High Performance Liquid Chromatography/Ultraviolet Detection (HPLC/UV): Single-Laboratory Validation, First Action 2021.10.
Frueh JL, Shu P, Vennard TR, Gray MA, Phillips SC. Frueh JL, et al. Among authors: gray ma. J AOAC Int. 2024 May 4:qsae038. doi: 10.1093/jaoacint/qsae038. Online ahead of print. J AOAC Int. 2024. PMID: 38704865
The Brazilian collaborative on antimicrobial stewardship: A value-based healthcare approach.
Fernandes RA, Carneiro M, Makdisse M, Adiwardana NS, Telles JP, Vidal CFL, Cotia ALF, Gray M; Brazilian Collaborative on Antimicrobial Stewardship. Fernandes RA, et al. Among authors: gray m. Braz J Infect Dis. 2024 Apr 25;28(2):103738. doi: 10.1016/j.bjid.2024.103738. Online ahead of print. Braz J Infect Dis. 2024. PMID: 38679060 Free PMC article. No abstract available.
3,021 results